
GC62348
MKI-1
Also known as N-(1H-benzimidazol-2-yl)-3-pyrrol-1-ylbenzamide
MKI-1, an inhibitor of MASTL (microtubule-associated serine/threonine kinase-like) with an IC50 of 9·9 μM, exerts antitumor and radiosensitizer activities through PP2A activation in breast cancer
ChemicalCAS1190277-80-5MW302.33FormulaC18H14N4O
- CAS number
- 1190277-80-5
- Molecular weight
- 302.33
- Formula
- C18H14N4O
- Solubility
- DMSO : 250 mg/mL (826·91 mM; Need ultrasonic)
- InChIKey
- XKDZPQAMBMLCDQ-UHFFFAOYSA-N
- Catalogue number
- GC62348
- Brand
- GLPBIO
Computed properties PubChem CID 27649598 · XLogP 3.2 · TPSA 62.7 Ų · H-bond donors 2
- XLogP
- 3.2
- TPSA
- 62.7 Ų
- H-bond donors
- 2
- H-bond acceptors
- 2
- Rotatable bonds
- 3
- Heavy atoms
- 23
SMILES C1=CC=C2C(=C1)NC(=N2)NC(=O)C3=CC(=CC=C3)N4C=CC=C4
Computed descriptors from PubChem (CID 27649598), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il